» Articles » PMID: 35702091

The Effects of Combination Therapy by Solid Lipid Nanoparticle and Dental Stem Cells on Different Degenerative Diseases

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2022 Jun 15
PMID 35702091
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cells have multiple therapeutic applications, as well as solid lipid nanoparticles. Solid lipid nanoparticle has appeared as a field of nano lipid technology with various potential applications in drug delivery, clinical medicine and research. Besides, the stem cells have a high proliferation rate and could differentiate into a variety of tissues. Stem cells derived from human dental pulp tissue differ from other sources of mesenchymal stem cells due to their embryonic neural crest source and neurotrophic potential. These consist of both dental pulp stem cells from dental pulp tissues of human permanent teeth and stem cells from human exfoliated deciduous teeth. With the emergence of stem cell banks, stem cells are considering for tissue engineering with respect to therapies attitude and regenerative medicine. The present study aimed to evaluate the advantages and disadvantages of the solid lipid nanoparticle and stem cells combination therapy in different therapeutic applications. The solid lipid nanoparticles have anticancer activity against tumors, induce neural differentiation in pluripotent stem cells, and regulate the mesenchymal stem cells. They also have immunomodulatory effects on human mesenchymal stem cells, the gene transfection efficiency, osteogenic differentiation and bone regeneration. But, the crucial health hazards related to stem cell transplantation such as immune rejection reactions and the interaction with other tissues and the effect of solid lipid nanoparticles must not be neglected. Overall, more experiments need to approve the synergism and antagonism effects of the stem cells and solid lipid nanoparticle combination therapy on different degenerative diseases.

Citing Articles

The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage.

Rostami M, Farahani P, Esmaelian S, Bahman Z, Hussein A, A Alrikabi H Stem Cell Rev Rep. 2024; 20(8):2062-2103.

PMID: 39150646 DOI: 10.1007/s12015-024-10770-y.


Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy.

Marwah H, Dewangan H Curr Pharm Des. 2024; 30(37):2922-2936.

PMID: 39150028 DOI: 10.2174/0113816128319233240725103706.


Tissue regeneration therapy by Nano composite scaffolds based on PLGA hydrogel embedded with human dental pulp stem cells: a systematic review.

Kamarehei F, Saleh G Am J Transl Res. 2024; 16(5):1521-1530.

PMID: 38883345 PMC: 11170567. DOI: 10.62347/QBKO6417.


Newly designed nanoparticle-drug delivery systems against infection: a systematic review.

Kamarehei F, Saleh G, Hemmati J, Gohari S Int J Clin Exp Pathol. 2024; 17(4):96-107.

PMID: 38716352 PMC: 11070434. DOI: 10.62347/BVWH1940.


Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.

Dhayalan M, Wang W, Riyaz S, Dinesh R, Shanmugam J, Irudayaraj S 3 Biotech. 2024; 14(2):57.

PMID: 38298556 PMC: 10825110. DOI: 10.1007/s13205-023-03901-8.


References
1.
Kuo Y, Rajesh R . Nerve growth factor-loaded heparinized cationic solid lipid nanoparticles for regulating membrane charge of induced pluripotent stem cells during differentiation. Mater Sci Eng C Mater Biol Appl. 2017; 77:680-689. DOI: 10.1016/j.msec.2017.03.303. View

2.
Wang Q, Liu P, Gong T, Sun X, Duan Y, Zhang Z . Uptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatoma. J Biomed Nanotechnol. 2014; 10(6):993-1003. DOI: 10.1166/jbn.2014.1776. View

3.
Scioli Montoto S, Muraca G, Ruiz M . Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects. Front Mol Biosci. 2020; 7:587997. PMC: 7662460. DOI: 10.3389/fmolb.2020.587997. View

4.
Goncalves L, Maestrelli F, Di Cesare Mannelli L, Ghelardini C, Almeida A, Mura P . Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide. Eur J Pharm Biopharm. 2016; 102:41-50. DOI: 10.1016/j.ejpb.2016.02.012. View

5.
Chabra S, Ranjan M, Bhandari R, Kaur T, Aggrawal M, Puri V . Solid lipid nanoparticles regulate functional assortment of mouse mesenchymal stem cells. J Stem Cells Regen Med. 2014; 7(2):75-9. PMC: 3908271. View